Guillain-Barre Risk After COVID-19 Vaccines Low, Surveillance Data Show
Risk of Guillain-Barré syndrome after COVID-19 vaccines was low overall, but unusually high after the Johnson & Johnson shot, surveillance data showed. Among 15.1 million doses of COVID-19 vaccines included in the Vaccine Safety Datalink, the unadjusted incidence rate of confirmed Guillain-Barré syndrome 1 to 21 days after receiving the Johnson & Johnson vaccine was […]
Cancer May Heighten Odds of Guillain-Barre Syndrome
People with certain types of cancer may have an increased risk of developing Guillain-Barré syndrome (GBS), according to a Danish population-based study. Over a 30-year period, 2% of individuals with GBS also had a recent cancer diagnosis, as compared to 0.6% of those in a matched control group (odds ratio [OR] 3.6, 95% CI 2.6-5.1), […]